Autochthonous and Travel Acquired Hepatitis E Virus in Australia.
Australia
autochthonous
hepatitis E virus
phylogenetics analysis
zoonotic
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
12
2020
accepted:
18
01
2021
entrez:
26
2
2021
pubmed:
27
2
2021
medline:
27
2
2021
Statut:
epublish
Résumé
Hepatitis E virus (HEV) is a common cause of acute viral hepatitis with significant morbidity and mortality, particularly in pregnant women. There are four major genotypes which can cause disease in humans. Genotypes 1 and 2 are usually associated with outbreaks and spread via facal/oral route or contaminated water. Genotypes 3 and 4 are zoonotic and usually associated with handling of pigs or consumption of contaminated pork. The strains circulating in Australia have never been characterized. The aims for this project are to identify the HEV genotypes found in Australia and link them to possible sources of transmission by phylogenetic analysis. Between 2015 and 2020, 91 HEV isolates were sequenced and genotyped using an in-house PCR. Sixty-six of these were also sequenced by using the international HEVnet primers. Genotypes were determined using the BLASTn program. Relatedness to other strains in Australia was determined by phylogenetic analyses of the HEVnet sequences. Isolates were also stratified by state of origin, gender, age, predisposing factors and travel history (if known). Of the 91 HEV isolates sequenced, 55 (60.4%) were genotype 1. There were 34 (37.4%) genotype 3 strains and two genotype 4 (2.2%). At least 20 of the genotype 1 strains have been linked to travel in India, and another three with Pakistan. Five of the "Indian" strains were closely related and are suspected to have originated in Gujarat. Phylogenetic analysis also showed that 12 genotype 3 strains were genetically related and potentially acquired in/from New South Wales, Australia. The two genotype 4 strains may have originated in China. This is the first study to describe the HEV isolates identified in Australia. The results infer that HEV may be acquired during overseas travel as well as locally, presumably from consumption of pork or pork-related products. The phylogenetic analyses also reveal clusters of infection originating from India and Pakistan. This study provides some insight into the source and epidemiology of HEV infection in Australia which may be used to guide public health procedure and enable the implementation of measures to deal with potential outbreaks of infection.
Sections du résumé
BACKGROUND
BACKGROUND
Hepatitis E virus (HEV) is a common cause of acute viral hepatitis with significant morbidity and mortality, particularly in pregnant women. There are four major genotypes which can cause disease in humans. Genotypes 1 and 2 are usually associated with outbreaks and spread via facal/oral route or contaminated water. Genotypes 3 and 4 are zoonotic and usually associated with handling of pigs or consumption of contaminated pork. The strains circulating in Australia have never been characterized.
RATIONALE/AIMS
UNASSIGNED
The aims for this project are to identify the HEV genotypes found in Australia and link them to possible sources of transmission by phylogenetic analysis.
MATERIALS AND METHODS
METHODS
Between 2015 and 2020, 91 HEV isolates were sequenced and genotyped using an in-house PCR. Sixty-six of these were also sequenced by using the international HEVnet primers. Genotypes were determined using the BLASTn program. Relatedness to other strains in Australia was determined by phylogenetic analyses of the HEVnet sequences. Isolates were also stratified by state of origin, gender, age, predisposing factors and travel history (if known).
RESULTS
RESULTS
Of the 91 HEV isolates sequenced, 55 (60.4%) were genotype 1. There were 34 (37.4%) genotype 3 strains and two genotype 4 (2.2%). At least 20 of the genotype 1 strains have been linked to travel in India, and another three with Pakistan. Five of the "Indian" strains were closely related and are suspected to have originated in Gujarat. Phylogenetic analysis also showed that 12 genotype 3 strains were genetically related and potentially acquired in/from New South Wales, Australia. The two genotype 4 strains may have originated in China.
DISCUSSION
CONCLUSIONS
This is the first study to describe the HEV isolates identified in Australia. The results infer that HEV may be acquired during overseas travel as well as locally, presumably from consumption of pork or pork-related products. The phylogenetic analyses also reveal clusters of infection originating from India and Pakistan. This study provides some insight into the source and epidemiology of HEV infection in Australia which may be used to guide public health procedure and enable the implementation of measures to deal with potential outbreaks of infection.
Identifiants
pubmed: 33633719
doi: 10.3389/fmicb.2021.640325
pmc: PMC7901960
doi:
Types de publication
Journal Article
Langues
eng
Pagination
640325Informations de copyright
Copyright © 2021 O’Keefe, Tracy, Yuen, Bonanzinga, Li, Chong, Nicholson and Jackson.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):784-90
pubmed: 18617784
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Indian J Med Microbiol. 2020 Jan-Mar;38(1):46-51
pubmed: 32719208
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862334
Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):789-796
pubmed: 31647558
J Virol Methods. 1999 Aug;81(1-2):109-13
pubmed: 10488768
J Infect Dis. 2019 Jul 31;220(5):802-810
pubmed: 31107958
Am J Trop Med Hyg. 2010 May;82(5):961-6
pubmed: 20439982
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
PLoS One. 2014 Jan 31;9(1):e87154
pubmed: 24498033
Vet Microbiol. 1999 Aug 16;68(1-2):95-105
pubmed: 10501166
Med J Aust. 1995 Mar 20;162(6):318-9
pubmed: 7715497
Am J Transplant. 2008 Aug;8(8):1744-8
pubmed: 18557740
Infect Genet Evol. 2017 Nov;55:343-349
pubmed: 28987806
Rev Med Virol. 2006 Jan-Feb;16(1):5-36
pubmed: 16175650
Nat Rev Dis Primers. 2017 Nov 16;3:17086
pubmed: 29154369
J Hepatol. 2018 Jun;68(6):1256-1271
pubmed: 29609832
Transfusion. 2016 Dec;56(12):3086-3093
pubmed: 27667133
J Gen Virol. 2020 Jul;101(7):692-698
pubmed: 32469300
Med J Aust. 2016 Apr 18;204(7):274
pubmed: 27078603
Vet Microbiol. 2009 Nov 18;139(3-4):270-8
pubmed: 19595519
Intervirology. 2017;60(5):201-206
pubmed: 29495017
PLoS One. 2018 Jun 7;13(6):e0198045
pubmed: 29879148
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
Hepatology. 2012 Apr;55(4):988-97
pubmed: 22121109
Med J Aust. 2015 Mar 2;202(4):209-11
pubmed: 25716605
Lancet. 2014 Nov 15;384(9956):1766-73
pubmed: 25078306
Emerg Infect Dis. 2012 Aug;18(8):1361-4
pubmed: 22840196
Intern Med J. 2020 May;50(5):643-644
pubmed: 32431030
Nucleic Acids Res. 2014 Jan;42(Database issue):D32-7
pubmed: 24217914
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862337
Euro Surveill. 2009 May 14;14(19):
pubmed: 19442399
J Clin Microbiol. 2000 Nov;38(11):3915-8
pubmed: 11060044
Intern Med J. 2019 Oct;49(10):1335-1336
pubmed: 31602774
Emerg Infect Dis. 2014 Nov;20(11):1940-2
pubmed: 25341023
Vox Sang. 2017 Oct;112(7):614-621
pubmed: 28833229
Clin Infect Dis. 2014 Sep 1;59(5):658-65
pubmed: 24855146
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
N S W Public Health Bull. 2014 Jun;24(4):171-5
pubmed: 24939227
Euro Surveill. 2018 Mar;23(12):
pubmed: 29589577
Lancet. 1993 Mar 27;341(8848):826
pubmed: 8096022
Liver Int. 2018 Apr;38(4):619-626
pubmed: 28834649
Zoonoses Public Health. 2019 Nov;66(7):773-782
pubmed: 31293095
Clin Microbiol Rev. 2014 Jan;27(1):116-38
pubmed: 24396139
J Gen Virol. 2011 Feb;92(Pt 2):269-78
pubmed: 21068219
J Gen Virol. 2004 Jan;85(Pt 1):89-95
pubmed: 14718623
N Z Med J. 2018 Feb 2;131(1469):38-43
pubmed: 29389927